Hearing intervention shows promise in protecting older adults at increased risk for cognitive decline

FHS
July 20, 2023
1:23 am

While the results were negative in the total study population, the hearing intervention slowed cognitive decline in older adults with mild to moderate hearing loss by 48% in a pre-specified segment of the study population consisting of the 238 people participating in an ongoing observational study of heart health.

Comparing severe outcome risks of SARS-CoV-2 Omicron BA.2.75, BQ.1, BA.4.6 to BA.5

Researchers determine the clinical severity of SARS-CoV-2 Omicron sub-lineages BA.4.6, BQ.1, and BA.2.75 relative to BA.5.

July 20, 2023

Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

May 20, 2024

Cerevel drug for Parkinson’s disease improved symptom control in trial

Cerevel Therapeutics, a neuroscience biotech that AbbVie is acquiring, reported that its drug for Parkinson’s disease improved motor symptom control as an add-on therapy in

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.